Rare Cancer News & Clinical Trials » Trial

Trial - CNS Tumor (100 unread)

1 2 3 ... 12

Pyrotinib Combined With Capecitabine and Bevacizumab for Patients With HER2 Positive Breast Cancer and Brain Metastases

Posted: December 1st, 2023, 3:00am GMT

Conditions: Breast Cancer With Brain Metastases
Interventions: Drug: pyrotinib+capecitabine+bevacizumab
Sponsors: Tongji Hospital
Recruiting
Comparison of The Effects Of General Anesthesia and PECS Block Methods on Blood Counts in Patients With Breast Cancer

Posted: November 30th, 2023, 3:00am GMT

Conditions: Breast Cancer
Interventions: Procedure: general anesthesia; Procedure: peripheral nerve blocks
Sponsors: Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Completed
MAAT For Young Adult Cancer Survivors

Posted: November 30th, 2023, 3:00am GMT

Conditions: Cancer
Interventions: Behavioral: MAAT-YS
Sponsors: University of Pittsburgh; St. Jude Children's Research Hospital; Indiana University School of Medicine
Not yet recruiting
BraiN20® Monitoring in Acute Stroke Undergoing Thrombectomy

Posted: November 29th, 2023, 3:00am GMT

Conditions: Acute Stroke; Mechanical Thrombectomy
Interventions: Device: BraiN20(R) monitoring of N20 somatosensory evoked potential
Sponsors: Fundació Institut Germans Trias i Pujol; European Innovation Council; Anagram-ESIC
Recruiting
A Study of Metabolic Agents Following Brain Radiation

Posted: November 29th, 2023, 3:00am GMT

Conditions: CNS Malignancy
Interventions: Diagnostic Test: F-DOPA Positron Emission Tomography; Diagnostic Test: Chemical Exchange Saturation Transfer Magnetic Resonance Imaging
Sponsors: Mayo Clinic
Enrolling by invitation
Ketorolac and Pregabalin Effects on breaSt Cancer (KePreSt)

Posted: November 29th, 2023, 3:00am GMT

Conditions: Early-stage Breast Cancer; Estrogen-receptor-positive Breast Cancer
Interventions: Procedure: Prospective data and sample collection; Drug: Ketorolac 10 Mg Oral Tablet; Drug: Pregabalin 75mg
Sponsors: Jules Bordet Institute; KU Leuven; University of Milan
Not yet recruiting
Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders

Posted: November 27th, 2023, 3:00am GMT

Conditions: Invasive PreNatal Diagnosis in a Context of Family History of Single-gene Disorders, Including; Sickle Cell Disease; Cystic Fibrosis; Fragile X Syndrome; Proximal Spinal Muscular Atrophy; Myotonic Dystrophy; Muscular Dystrophy, Duchenne; Muscular Dystrophy, Becker; Neurofibromatosis-Noonan Syndrome; Huntington Disease; Hemophilia A; Hemophilia B; MODY2 Diabetes; X-Linked Hydrocephalus; Autosomal Recessive Polycystic Kidney Disease
Interventions: Biological: Blood sample
Sponsors: Assistance Publique - Hôpitaux de Paris
Not yet recruiting
The Impact of Expressive Emotional Writing on Facilitating Grief Resolution in Adults With Spinal Cord Injury

Posted: November 27th, 2023, 3:00am GMT

Conditions: Spinal Cord Injuries; Transverse Myelitis
Interventions: Behavioral: expressive writing
Sponsors: University of Alabama at Birmingham
Not yet recruiting
Effect of Intraperitoneal Ropivacaine on Visceral Pain After Laparoscopic Gastrectomy

Posted: November 24th, 2023, 3:00am GMT

Conditions: Laparoscopic Gastrectomy; Ropivacaine
Interventions: Drug: 0.5% Ropivacaine; Drug: Saline
Sponsors: SanQing Jin
Not yet recruiting
Non Interventional German Leptomeningeal Disease Register

Posted: November 24th, 2023, 3:00am GMT

Conditions: Meningeal Neoplasms; Leptomeningeal Disease
Interventions: Other: No intervention
Sponsors: University Hospital Tuebingen
Not yet recruiting
Cognitive Function and Glymphatic System in Children With Epilepsy

Posted: November 22nd, 2023, 3:00am GMT

Conditions: Epilepsy; Cognitive Dysfunction; Seizure, Epileptic
Interventions: Device: Threshold IMT; Drug: Antiepileptic medication
Sponsors: Ege University
Not yet recruiting
Effect of Ketamine on Intraoperative Motor Evoked Potentials

Posted: November 21st, 2023, 3:00am GMT

Conditions: Spine Fusion; Spine Tumor; Spinal Stenosis
Interventions: Drug: Ketamine
Sponsors: University of California, San Francisco
Not yet recruiting
Clinical Study of Dexmedetomidine Administered Intranasally to Relieve Perioperative Anxiety and Depression in Patients With Colorectal Tumors

Posted: November 20th, 2023, 3:00am GMT

Conditions: Relieving Perioperative Anxiety and Depression in Colorectal Cancer Patients
Interventions: Drug: Dexmedetomidine administered intranasally
Sponsors: First Affiliated Hospital of Chongqing Medical University
Recruiting
The Effect of GD-iExo-003 in Acute Ischemic Stroke

Posted: November 20th, 2023, 3:00am GMT

Conditions: Acute Ischemic Stroke
Interventions: Drug: exosomes derived from human induced pluripotent stem cell for injection; Drug: a placebo of exosomes derived from human induced pluripotent stem cell for injection
Sponsors: Xuanwu Hospital, Beijing; Guidon Pharmaceutics Ltd.
Not yet recruiting
Promoting Prosocial Behavior in Syndromic Intellectual and Developmental Disabilities

Posted: November 20th, 2023, 3:00am GMT

Conditions: Telomeric 22Q13 Monosomy Syndrome; Tuberous Sclerosis; Hamartoma Syndrome, Multiple; Fragile X Syndrome; Angelman Syndrome; Rett Syndrome; Chromosome 15Q, Partial Deletion; Creatine Deficiency, X-linked
Interventions: Behavioral: Functional Behavioral Training (FBT); Other: Positive Parenting Strategies-Treatment as Usual
Sponsors: Rush University Medical Center; Emory University
Enrolling by invitation
The Effects of Anesthetics on Brain Network Connectivity in Patients With Supratentorial Glioma

Posted: November 20th, 2023, 3:00am GMT

Conditions: Brain Network Connectivity; Postoperative Delirium; Dexmedetomidine; Propofol
Interventions: Drug: Dexmedetomidine; Drug: Propofol
Sponsors: Beijing Tiantan Hospital
Recruiting
xPedite: An Observational Study to Expedite DIPG and DMG Research

Posted: November 20th, 2023, 3:00am GMT

Conditions: Oncology; DIPG; DMG
Sponsors: xCures; SonALAsense, Inc.
Not yet recruiting
Trotabresib in Combination With Vinorelbine and Radiation Therapy for the Treatment of HER2+ Breast Cancer With Central Nervous System or Leptomeningeal Metastasis

Posted: November 17th, 2023, 3:00am GMT

Conditions: Breast Carcinoma; Metastatic Malignant Neoplasm in the Brain; Metastatic Malignant Neoplasm in the Leptomeninges
Interventions: Procedure: Biospecimen Collection; Procedure: Computed Tomography; Procedure: Magnetic Resonance Imaging; Radiation: Radiation Therapy; Procedure: Resection; Drug: Trotabresib; Drug: Vinorelbine
Sponsors: Northwestern University; National Cancer Institute (NCI)
Not yet recruiting
An Exploratory Study to Evaluate Attention Biases in Adults With Multiple Sclerosis, Breast Cancer, and Lung Cancer

Posted: November 17th, 2023, 3:00am GMT

Conditions: Multiple Sclerosis; Lung Cancer; Breast Cancer
Interventions: Device: CT-100-D-004-A; Device: CT-100-D-004-B
Sponsors: Click Therapeutics, Inc.
Recruiting
Intravenous Lidocaine Infusion Reduce Postoperative Pulmonary Complications in Patients Undergoing Minimally Invasive Esophagectomy

Posted: November 17th, 2023, 3:00am GMT

Conditions: Postoperative Pneumonia; Postoperative Pulmonary Atelectasis; Postoperative Pulmonary Edema
Interventions: Drug: intravenous lidocaine infusion; Drug: Saline
Sponsors: Sichuan Cancer Hospital and Research Institute
Not yet recruiting
Bupivacaine Liposome Serrate Anterior Plane Block vs Traditional Thoracic Paravertebral Block

Posted: November 16th, 2023, 3:00am GMT

Conditions: Lung Cancer
Interventions: Combination Product: Bupivacaine Liposome SAPB; Combination Product: Traditional TPVB
Sponsors: Shiyou Wei
Recruiting
Efficacy of T-Dxd in the Treatment of HER2-positive BCBM After Prior Pyrotinib

Posted: November 16th, 2023, 3:00am GMT

Conditions: Breast Cancer
Interventions: Drug: T-DXd
Sponsors: Beijing 302 Hospital
Recruiting
CONFIDENCE-AI Financial Education for Caregivers (CONFIDENCE-AI)

Posted: November 16th, 2023, 3:00am GMT

Conditions: Alzheimer Disease; Dementia; Caregiver Burden; Financial Stress
Interventions: Behavioral: CONFIDENCE-AI
Sponsors: Case Western Reserve University
Not yet recruiting
A Study of Cabozantinib and Nivolumab With Radiation Therapy for People With Renal Cell Carcinoma That Has Spread to the Brain

Posted: November 15th, 2023, 3:00am GMT

Conditions: Metastatic Renal Cell Carcinoma; Brain Metastases
Interventions: Drug: Cabozantinib; Device: Nivolumab; Radiation: Stereotactic Radiosurgery (SRS)
Sponsors: Memorial Sloan Kettering Cancer Center; Exelixis
Recruiting
[90Y]Y-PTT Endoradiotherapy in CNS Lymphoma Patients

Posted: November 15th, 2023, 3:00am GMT

Conditions: CNS Lymphoma
Interventions: Drug: [90Y]Y-PentixaTher
Sponsors: Pentixapharm AG
Recruiting
Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial

Posted: November 15th, 2023, 3:00am GMT

Conditions: Low Grade Glioma; Malignant Brain Glioma; Malignant Brain Neoplasm; Meningioma
Interventions: Procedure: Biospecimen Collection; Procedure: Computed Tomography; Drug: Dexamethasone; Procedure: Magnetic Resonance Imaging; Other: Questionnaire Administration
Sponsors: Emory University; National Cancer Institute (NCI)
Not yet recruiting
Patient Reported Outcomes Using Mepitel Film During Radiotherapy

Posted: November 15th, 2023, 3:00am GMT

Conditions: Radiodermatitis; Breast Neoplasms; Side Effect
Interventions: Other: Mepitel Film
Sponsors: Odense University Hospital; Herning Hospital; Vejle Hospital
Completed
Different Modalities of Management of Odontogenic Keratocysts

Posted: November 15th, 2023, 3:00am GMT

Conditions: Odontogenic Cysts
Interventions: Procedure: Enucleation+ Peripheral Ostectomy+Carnoy's solution chemical cauterization (E+CS + PO); Procedure: Decompression/ marsupialization (D/M); Procedure: Enucleation (E); Procedure: Enucleation+Carnoy's solution (E+CS); Procedure: Enucleation+ Peripheral Ostectomy (E+ PO)
Sponsors: Qassim University; Al-Azhar University
Recruiting
Immune Checkpoint Inhibitors Intrathecal Injection in Patients With Leptomeningeal Metastases in NSCLC

Posted: November 15th, 2023, 3:00am GMT

Conditions: NSCLC Associated With Leptomeningeal Metastases
Interventions: Drug: Tislelizumab, pemetrexed
Sponsors: West China Hospital
Not yet recruiting
Nutritional Therapy in Late-onset Pompe Disease

Posted: November 14th, 2023, 3:00am GMT

Conditions: Pompe Disease; Muscle Loss; Obesity; Nutrition Poor; Lysosomal Storage Diseases; Glycogen Storage Disease Type II; Glycogen Storage Disease Type II Late Onset; Glycogen Storage Disease Type II, Adult
Interventions: Dietary Supplement: Multi-ingredient supplement (PDT-MIS); Dietary Supplement: Placebo (PLA)
Sponsors: McMaster University
Not yet recruiting
UCMSCs as Treatment for Patients With Acute Ischemic Stroke (Stroke Neuroncell-EX)

Posted: November 13th, 2023, 3:00am GMT

Conditions: Acute Ischemic Stroke
Interventions: Biological: Neuroncell-EX; Other: Placebo
Sponsors: Cytopeutics Sdn. Bhd.; National University of Malaysia
Not yet recruiting
Study of Oral JYP0322 in Patients With Locally Advanced or Metastatic Cancer Targeting ROS1 Molecular Fusion.

Posted: November 13th, 2023, 3:00am GMT

Conditions: Protein Kinase Inhibitors; Other Protocol Specified Criteria; Lung Neoplasms; Brain Neoplasms
Interventions: Drug: JYP0322
Sponsors: Guangzhou JOYO Pharma Co., Ltd
Recruiting
MRI Gadopiclenol Enhanced Imaging of CNS Tumors

Posted: November 10th, 2023, 3:00am GMT

Conditions: Image
Interventions: Device: CE MRI on 0.064T Scanner; Drug: Gadopiclenol
Sponsors: Medical University of South Carolina; Guerbet
Not yet recruiting
$Permalink for 'Combination of Everolimus and 177Lu-DOTATATE in the Treatment of Grades 2 and 3 Refractory Meningioma: a Phase IIb Clinical Trial'$
Combination of Everolimus and 177Lu-DOTATATE in the Treatment of Grades 2 and 3 Refractory Meningioma: a Phase IIb Clinical Trial

Posted: November 10th, 2023, 3:00am GMT

Conditions: Meningioma
Interventions: Drug: Everolimus
Sponsors: Central Hospital, Nancy, France
Not yet recruiting
Survivorship After HNC: A Single Arm Trial Evaluating Adherence to Follow-up

Posted: November 10th, 2023, 3:00am GMT

Conditions: Head and Neck Cancer; Survivorship
Interventions: Other: Motivational interviewing counselling session
Sponsors: Western University, Canada
Not yet recruiting
Analgesia Nociception Index-guided Anesthesia and Standard Anesthesia

Posted: November 9th, 2023, 3:00am GMT

Conditions: Gastric Cancer
Interventions: Behavioral: Analgesia nociception index-guided anesthesia; Behavioral: Standard anesthesia
Sponsors: Ajou University School of Medicine
Not yet recruiting
The Effect of Melatonin Supplementation on Fatigue Symptoms During Chemotherapy Treatment of Breast Cancer Patients

Posted: November 9th, 2023, 3:00am GMT

Conditions: Breast Cancer
Interventions: Dietary Supplement: Melatonin
Sponsors: Harokopio University
Completed
STALL vs Sole Local Wound Infiltration in Laparoscopic Cholecystectomy - Double-blinded Randomized Controlled Trial

Posted: November 8th, 2023, 3:00am GMT

Conditions: Cholelithiasis; Cholecystitis; Gallbladder Cancer
Interventions: Procedure: single transversus abdominis laparoscopy-guided plane block; Procedure: local trocar site ropivacaine infiltration
Sponsors: Helsinki University Central Hospital
Not yet recruiting
The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients

Fetched: November 7th, 2023, 5:01am GMT

Conditions: Glioblastoma; High-grade Glioma; Glioblastoma, IDH-wildtype; Glioblastoma, IDH-mutant; Glioblastoma Multiforme, Adult; Astrocytoma, Grade IV; Astrocytoma, Grade III; Astrocytoma, Malignant; Brain Neoplasms; Brain Neoplasm, Primary; Brain Neoplasms, Adult; Brain Neoplasm, Malignant
Interventions: Procedure: Supramaximal resection; Procedure: Maximal safe resection
Sponsors: Jasper Gerritsen; Haaglanden Medical Centre; Universitaire Ziekenhuizen KU Leuven; University Hospital Heidelberg; Technical University of Munich; Insel Gruppe AG, University Hospital Bern; Massachusetts General Hospital; University of California, San Francisco
Recruiting
Comparing the QoR of PECS Block and GA in Breast-conserving Surgery With Sentinel Lymph Node Biopsy

Posted: November 7th, 2023, 3:00am GMT

Conditions: Breast Cancer; Pectoral Nerves Block; Breast-Conserving Surgery; Sentinel Lymph Node Biopsy
Interventions: Combination Product: PECS II combined with intercostal nerve blockade;; Combination Product: General anesthesia with laryngeal mask
Sponsors: Jun Zhang
Recruiting
En Bloc Resection Versus Separation Surgery Combined With Radiotherapy for the Treatment of Spinal Oligometastatic Tumor-A Multicenter, Prospective, Randomized, Controlled Study.

Posted: November 7th, 2023, 3:00am GMT

Conditions: Spinal Metastases; Spinal Tumor; Radiotherapy; Malignant Bone Tumor; Surgery
Interventions: Procedure: total en bloc spondylectomy
Sponsors: Shanghai Changzheng Hospital; Peking University Third Hospital; Peking University People's Hospital; Henan Cancer Hospital; First Affiliated Hospital, Sun Yat-Sen University; Sun Yat-sen University; Zhejiang University; Tianjin Hospital; The First Affiliated Hospital of Nanchang University; The Third Affiliated Hospital of Southern Medical University
Recruiting
Study of Human Brain-Gut Axis and Gut Microbiome in Patients With Brain Lesions - Repository for Neuroscience Research

Posted: November 6th, 2023, 3:00am GMT

Conditions: Malignant Central Nervous System Neoplasm
Interventions: Other: Non-Interventional Study
Sponsors: Mayo Clinic
Not yet recruiting
Esketamine Combined With Pregabalin on CPSP in Spinal Patients.

Posted: November 6th, 2023, 3:00am GMT

Conditions: Esketamine; Pregabaline; Chronic Post Operative Pain
Interventions: Drug: S-ketamine and pregabalin; Drug: Normal saline and placebo capsule
Sponsors: Beijing Tiantan Hospital
Not yet recruiting
IDEAL Study: Blinded RCT for the Impact of AI Model for Cerebral Aneurysms Detection on Patients' Diagnosis and Outcomes

Posted: November 6th, 2023, 3:00am GMT

Conditions: Intracranial Aneurysm; CT Angiography; Deep Learning; Double Bind Interaction
Interventions: Device: True-AI-integrated intracranial aneurysms diagnosis strategy; Device: Sham-AI-integrated intracranial aneurysms diagnosis strategy
Sponsors: Jinling Hospital, China
Not yet recruiting
First-in-human Experience Using Novel Ultraflexible Low-impedance Electrode Arrays: an IDEAL Stage 1 Study

Posted: November 3rd, 2023, 2:00am GMT

Conditions: Epilepsy; Focal Cortical Dysplasia
Interventions: Device: Insertion of electrode during planned neurosurgery for epilepsy
Sponsors: Great Ormond Street Hospital for Children NHS Foundation Trust
Not yet recruiting
A Retrospective Study of Newly-diagnosed PCNSL Treated With a Methotrexate (MTX) and Orelabrutinib-based Regimen

Posted: November 3rd, 2023, 2:00am GMT

Conditions: Primary Central Nervous System Lymphoma
Interventions: Drug: Orelabrutinib
Sponsors: Huashan Hospital
Active, not recruiting
Randomized Controlled Study Evaluating the Efficacy of Hypnosis in Nuclear Medicine

Posted: November 3rd, 2023, 2:00am GMT

Conditions: Cancer; Myocarditis; Alzheimer Disease; Parkinson
Interventions: Other: Ericksonian Hypnosis; Other: Hypnosis
Sponsors: Central Hospital, Nancy, France
Recruiting
Comparison Effectiveness of Rectal Misoprostol & Intravenous Tranexamic Acid Reducing Hemorrhage in Myomectomy

Posted: November 2nd, 2023, 2:00am GMT

Conditions: Hemorrhage, Surgical; Myoma;Uterus; Effect of Drug; Postoperative Hemorrhage; Postoperative Complications
Interventions: Drug: Cytotec 200Mcg Tablet; Drug: Transamine
Sponsors: Ankara Etlik City Hospital
Active, not recruiting
The North Kynouria Project

Posted: November 2nd, 2023, 2:00am GMT

Conditions: Cardiovascular Diseases; Heart Diseases; Cerebrovascular Disease; Coronary Disease; Dyslipidemias; Stroke (CVA) or TIA; Myocardial Infarction; Hypertension; Diabetes Mellitus; Peripheral Artery Disease
Interventions: Behavioral: Patient counselling
Sponsors: University Hospital, Ioannina; Hellenic Stroke Organization; Municipality of North Kynouria; Greece 2021 Committee; Astros Health Care Center
Recruiting
A Drug-Drug Interaction Study of LY3537982 on Midazolam, Digoxin, and Rosuvastatin in Healthy Participants

Posted: November 1st, 2023, 2:00am GMT

Conditions: Healthy
Interventions: Drug: LY3537982; Drug: Digoxin; Drug: Rosuvastatin; Drug: Midazolam; Drug: Midazolam
Sponsors: Eli Lilly and Company; Loxo Oncology, Inc.
Not yet recruiting
Ketamine-midazolam as a Sedative Agent in Endoscopic Retrograde Cholangiopancreatography.

Posted: November 1st, 2023, 2:00am GMT

Conditions: Cholangitis; Pancreatic Cancer; Choledocholithiasis; Choledochal Cyst
Interventions: Drug: Ketamine; Drug: Midazolam; Drug: Pethidin
Sponsors: National University of Malaysia
Recruiting
Stellate Ganglion Block in Parkinson's Disease

Posted: November 1st, 2023, 2:00am GMT

Conditions: Stellate Ganglion; Parkinson Disease
Interventions: Diagnostic Test: Treatment （Stellate ganglion block；Oral standard anti-Parkinson's drugs）; Diagnostic Test: Treatment （Oral standard anti-Parkinson's drugs）
Sponsors: Zhujiang Hospital
Recruiting
Clinical Feasibility of Brain Radiotherapy Using Synthetic CTs in an MRI-only Workflow

Posted: October 30th, 2023, 2:00am GMT

Conditions: Brain Tumor, Primary; Brain Tumor - Metastatic
Interventions: Radiation: brain radiotherapy
Sponsors: University of Erlangen-Nürnberg Medical School
Not yet recruiting
Plasma Extracellular Vesicles in Meningioma Patients

Posted: October 27th, 2023, 2:00am GMT

Conditions: Meningioma
Interventions: Other: Explorative biomarker study
Sponsors: University Hospital Heidelberg
Recruiting
A Study of Avutometinib for People With Solid Tumor Cancers

Posted: October 27th, 2023, 2:00am GMT

Conditions: Refractory Cancer; CNS Tumors; CNS Tumor, Adult; CNS Tumor, Childhood; MAP Kinase Family Gene Mutation; NF1; Plexiform Neurofibroma; Low-grade Glioma; Optic Pathway Gliomas; Neuroblastoma; Primary Brain Tumor; Solid Tumor; Solid Tumor, Adult; Solid Carcinoma; Central Nervous System Tumor
Interventions: Drug: Avutometinib
Sponsors: Memorial Sloan Kettering Cancer Center
Recruiting
11C-Metomidate PET/CT for Endocrine Hypertension and Characterisation of Adrenal Tumours

Posted: October 25th, 2023, 2:00am GMT

Conditions: Primary Aldosteronism Due to Aldosterone Producing Adenoma; Primary Aldosteronism; Adrenal Tumors
Interventions: Combination Product: 11C-Metomidate PET/CT imaging at Clinical Imaging Research Centre
Sponsors: Changi General Hospital; National University Health System, Singapore; Clinical Imaging Research Centre; Singapore General Hospital; Tan Tock Seng Hospital; Khoo Teck Puat Hospital; Ng Teng Fong General Hospital; Sengkang General Hospital
Recruiting
ASCENT Intervention for Brain Tumor Patients

Posted: October 25th, 2023, 2:00am GMT

Conditions: Malignant Brain Tumor; Glioma; Coping Skills; Distress, Emotional
Interventions: Behavioral: Psychosocial intervention; Other: Usual supportive care
Sponsors: Massachusetts General Hospital
Not yet recruiting
Discovery of New Cancer in the 1-year Follow-up After Ischemic Stroke in Patients at Risk: The INVISIBLE-1 Study

Posted: October 25th, 2023, 2:00am GMT

Conditions: Cancer-related Stroke; Paraneoplastic Coagulopathy; Occult Cancer; Ischemic Stroke; Embolic Stroke of Undetermined Source; D-dimer
Sponsors: Insel Gruppe AG, University Hospital Bern
Recruiting
Development of MRF for Characterization of Brain Tumors After Radiotherapy

Posted: October 25th, 2023, 2:00am GMT

Conditions: Brain Tumor; Brain Necrosis; Brain Metastases
Interventions: Procedure: MRF in conjunction with IVIM MRI without contrast
Sponsors: Case Comprehensive Cancer Center; The Cleveland Clinic
Not yet recruiting
cCeLL - Ex Vivo (Confocal Fluorescence Endomicroscopy) for Intraoperative Brain Tumor Diagnosis

Posted: October 24th, 2023, 2:00am GMT

Conditions: Benign Brain Tumor; Malignant Brain Tumor
Interventions: Diagnostic Test: cCeLL Ex Vivo
Sponsors: VPIX Medical; Unity Health Toronto; Korea University Anam Hospital; Samsung Medical Center; Seoul National University Hospital
Not yet recruiting
The Effect of Bilateral Rectus Sheath Block Versus Wound Infiltration in Gynecooncological Patients

Posted: October 23rd, 2023, 2:00am GMT

Conditions: Postoperative Pain
Interventions: Drug: Bupivacain
Sponsors: Dr. Lutfi Kirdar Kartal Training and Research Hospital
Recruiting
Remimazolam Versus Propofol for General Anesthesia Induction in Patients on Renin-angiotensin System Blockers Undergoing Robot-assisted Laparoscopic Prostatectomy

Posted: October 23rd, 2023, 2:00am GMT

Conditions: Prostate Tumor
Interventions: Drug: remimazolam; Drug: Propofol
Sponsors: Yonsei University
Not yet recruiting
Clinical Applicantion of Multi-Tracer PET/MR Imaging in Neurological Disorders/Disease

Posted: October 20th, 2023, 2:00am GMT

Conditions: Alzheimer Disease; Parkinson Disease; Epilepsy; Malignant Brain Tumor
Interventions: Device: PET/MR
Sponsors: Xuanwu Hospital, Beijing; Peking University Cancer Hospital & Institute; Shanghai Zhongshan Hospital; Wuhan TongJi Hospital; Henan Provincial People's Hospital; Sun Yat-sen University; Shanghai East Hospital of Tongji University; The First Affiliated Hospital with Nanjing Medical University; Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences; Shanghai Jiao Tong University School of Medicine
Recruiting
Study of Intravenous Telisotuzumab Vedotin in Combination Osimertinib or Standard of Care Chemotherapy to Assess Change in Disease Activity in Adult Participants With Non-Small Cell Lung Cancer That Has a Mutation in the Epidermal Growth Factor Receptor

Posted: October 20th, 2023, 2:00am GMT

Conditions: Non-Small Cell Lung Cancer
Interventions: Drug: Telisotuzumab Vedotin; Drug: Osimertinib; Drug: Cisplatin; Drug: Carboplatin; Drug: Pemetrexed
Sponsors: AbbVie
Not yet recruiting
RE-irradiation of Diffuse MIdline Glioma paTients

Posted: October 20th, 2023, 2:00am GMT

Conditions: Diffuse Midline Glioma, H3 K27M-Mutant; Diffuse Intrinsic Pontine Glioma; Diffuse Glioma; Pontine Tumors; Thalamic Tumor; Brain Tumor, Pediatric
Interventions: Radiation: Re-irradiation
Sponsors: Rigshospitalet, Denmark; Aarhus University Hospital; Sahlgrenska University Hospital, Sweden; Karolinska University Hospital; Radiumhospitalet, Oslo University Hospital
Not yet recruiting
A Drug-Drug Interaction Study Evaluating the Perpetrator Potential of DC-806 on Cocktails of CYP450 Enzyme and Transporter Substrates in Healthy Participants

Posted: October 20th, 2023, 2:00am GMT

Conditions: Healthy Participants
Interventions: Drug: DC-806; Drug: Midazolam; Drug: Repaglinide; Drug: Digoxin; Drug: Rosuvastatin
Sponsors: DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company
Active, not recruiting
LIBERTY: Liquid Biopsy to Diagnose and Monitor CNS Involvement in High-risk B Cell Non-Hodgkin Lymphoma

Posted: October 19th, 2023, 2:00am GMT

Conditions: Non-hodgkin Lymphoma, B Cell
Interventions: Diagnostic Test: ctDNA detection
Sponsors: Swiss Group for Clinical Cancer Research
Not yet recruiting
Comparison of the Efficacy and Safety of Duloxetine Augmented With Gabapentin and Duloxetine Augmented With Amitriptyline vs Duloxetine Alone in Chemotherapy -Induced Neuropathy

Posted: October 19th, 2023, 2:00am GMT

Conditions: Neuropathy in Cacer Patien
Interventions: Drug: Duloxetine alone; Drug: Duloxetine augmented with gabapentin; Drug: Duloxetine augmented with amitriptyline (as combined therapy)
Sponsors: Beni-Suef University
Not yet recruiting
A Phase II Study of T-DXd Plus SRT in HER2-positive Breast Cancer Brain Metastases

Posted: October 18th, 2023, 2:00am GMT

Conditions: Breast Cancer; Brain Metastases; Radiotherapy
Interventions: Drug: Combination use of SRT with T-DXd
Sponsors: Fudan University
Not yet recruiting
Personalized Obstructive Sleep Apnea Treatment and Effects on Alzheimer's Disease Biomarkers and Cognition Among Blacks

Posted: October 18th, 2023, 2:00am GMT

Conditions: Sleep Apnea
Interventions: Other: Standard of Care; Behavioral: Personalized OSA Treatment
Sponsors: University of Miami; National Institute on Aging (NIA)
Not yet recruiting
Drug Utilisation of Mysimba/Contrave

Posted: October 18th, 2023, 2:00am GMT

Conditions: Obesity
Sponsors: Currax Pharmaceuticals
Completed
A Feasibility Analysis of an in Vivo CONVIVO Endomicroscopy During Brain Surgery.

Posted: October 17th, 2023, 2:00am GMT

Conditions: Brain Tumor
Interventions: Device: CONVIVO
Sponsors: Northwell Health
Recruiting
Pain Relieving Potentials of Combination of Oral Duloxetine and Intravenous Magnesium Sulphate in Post Mastectomy Pain

Posted: October 17th, 2023, 2:00am GMT

Conditions: Post-mastectomy Pain Syndrome
Interventions: Drug: Duloxetine and magnesium sulphate; Drug: Duloxetine; Drug: placebo
Sponsors: National Cancer Institute, Egypt
Recruiting
Translation and Validation of the COMM and ASI-SR

Posted: October 16th, 2023, 2:00am GMT

Conditions: Opioid Use; Opioid Use Disorder; Alcohol Use Disorder; Pain, Chronic
Interventions: Diagnostic Test: Current Opioid Misuse Measure (COMM)-SWE; Diagnostic Test: Oral fluid drug test; Diagnostic Test: PETh; Diagnostic Test: ASI-SR; Diagnostic Test: AUDIT; Diagnostic Test: DUDIT; Diagnostic Test: Brief Pain Inventory - BPI; Diagnostic Test: Patient Global Impression of Change PGIC; Diagnostic Test: GAD-7; Diagnostic Test: Patient Health questionnaire (PHQ9); Diagnostic Test: DBS - cannabis test; Other: Sample of Blood for later DNA and immunological analysis in future studies
Sponsors: Uppsala University; The Kamprad Family Foundation for Entrepreneurship, Research & Charity
Not yet recruiting
Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders

Posted: October 13th, 2023, 2:00am GMT

Conditions: Neurodevelopmental Disorders; Autism; Autism Spectrum Disorder; Fragile X Syndrome; Tuberous Sclerosis; 22Q11 Deletion Syndrome; 22Q11 Deletion; ADHD; Tic Disorders; Tourette Syndrome; Tourette Syndrome in Children; Tourette Syndrome in Adolescence; ADHD - Combined Type; ADHD Predominantly Inattentive Type; ADHD, Predominantly Hyperactive - Impulsive; Provisional Tic Disorder; Anxiety; Anxiety Disorders; Agoraphobia; Generalized Anxiety; Generalized Anxiety Disorder; Social Anxiety; Social Anxiety Disorder; Unspecified Anxiety Disorder; Other Specified Anxiety Disorders; Separation Anxiety
Interventions: Drug: Sertraline; Other: Placebo
Sponsors: Anagnostou, Evdokia, M.D.; Azrieli Foundation; Canadian Institutes of Health Research (CIHR); Ontario Brain Institute; Holland Bloorview Kids Rehabilitation Hospital; McMaster University; Western University; Queen's University; University of Alberta; Alberta Health services; St. Justine's Hospital; Dalhousie University; Unity Health Toronto; University of Toronto; The Hospital for Sick Children
Not yet recruiting
Multimodal Deep Learning for the Diagnosis and Assessment of Alzheimer's Disease

Posted: October 13th, 2023, 2:00am GMT

Conditions: Alzheimer Disease; Mild Cognitive Impairment
Interventions: Diagnostic Test: gait video; speech video; facial expression video;
Sponsors: First Hospital of China Medical University
Not yet recruiting
$Permalink for 'Allogeneic Second-generation CD19-CAR T Cells for Pediatric Relapsed/Refractory B-ALL'$
Allogeneic Second-generation CD19-CAR T Cells for Pediatric Relapsed/Refractory B-ALL

Posted: October 12th, 2023, 2:00am GMT

Conditions: B-cell Acute Lymphoblastic Leukemia
Interventions: Drug: CD19-CAR_Lenti_ALLO
Sponsors: Bambino Gesù Hospital and Research Institute
Not yet recruiting
Impact of Confirmed Autoimmune Encephalitis on Brain Glucose Metabolism : a Prospective FDG PET Study

Posted: October 12th, 2023, 2:00am GMT

Conditions: Autoimmune Encephalitis
Interventions: Other: FDG PET
Sponsors: Assistance Publique - Hôpitaux de Paris
Not yet recruiting
Ketamine-assisted Therapy for Patients With Pancreatic Ductal Adenocarcinoma

Posted: October 11th, 2023, 2:00am GMT

Conditions: Pancreatic Ductal Adenocarcinoma; Pain, Acute
Interventions: Drug: Ketamine; Behavioral: Meaning and Purpose therapy
Sponsors: Brian Anderson, MD
Not yet recruiting
MRIdian "RADAR" Trial

Posted: October 11th, 2023, 2:00am GMT

Conditions: Metastatic Epidural Spinal Cord Compression; Spinal Cord Compression
Interventions: Radiation: ViewRay MRIdian Stereotactic Radiosurgery
Sponsors: University of Miami; Viewray Inc.
Not yet recruiting
Lactoferrin in Patients With Hepatic Encephalopathy

Posted: October 9th, 2023, 2:00am GMT

Conditions: Hepatic Encephalopathy
Interventions: Drug: Lactoferrin Bovine
Sponsors: Al-Azhar University
Not yet recruiting
Study of BDTX-1535 in Recurrent High-Grade Glioma (HGG) Participants With EGFR Alterations or Fusions

Posted: October 9th, 2023, 2:00am GMT

Conditions: High Grade Glioma
Interventions: Drug: BDTX-1535
Sponsors: St. Joseph's Hospital and Medical Center, Phoenix; Ivy Brain Tumor Center; Barrow Neurological Institute
Recruiting
The Living With a Long-Term Condition Study

Posted: October 9th, 2023, 2:00am GMT

Conditions: Asthma; Atrial Fibrillation; Cancer; Cerebrovascular Disorders; Stroke; CKD; Copd; Fibromyalgia; Pain; Heart Diseases; Heart Disease Chronic; Dementia; Diabetes; Epilepsy; Heart Failure; High Blood Pressure; Hypertension; Hiv; AIDS; IBD; IBS; Liver Diseases; Long COVID; Lupus Erythematosus; Multiple Sclerosis; Obesity; Osteoarthritis; Arthritis; Rheumatoid Arthritis; Osteoporosis; Parkinson Disease; Sickle Cell Disease; Hepatitis; Endometriosis; PCOS; Neurological Disorder; POTS - Postural Orthostatic Tachycardia Syndrome; MND (Motor Neurone DIsease); Cystic Fibrosis; Migraine; Spondylitis; Celiac Disease; Hidradenitis Suppurativa; Eczema; ME/CFS
Interventions: Diagnostic Test: Living with LTC Questionnaire
Sponsors: King's College London
Recruiting
Targeting Osteosarcopaenia and Multimorbidity for Frailty Prevention

Posted: October 9th, 2023, 2:00am GMT

Conditions: Stroke; Traumatic Brain Injury; Knee Osteoarthritis; Breast Cancer
Sponsors: Tan Tock Seng Hospital; Rehabilitation Research Institute of Singapore (RRIS); Woodlands Health (WH)
Not yet recruiting
Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer

Posted: October 9th, 2023, 2:00am GMT

Conditions: Breast Cancer; Brain Metastases
Interventions: Diagnostic Test: Brain Imaging with 18F-FES
Sponsors: Weill Medical College of Cornell University; GE Healthcare
Not yet recruiting
Effectiveness of Rehabilitation in Adults Suffering From Persistent Concussion Symptoms

Posted: October 6th, 2023, 2:00am GMT

Conditions: Postconcussion Syndrome; Mild Traumatic Brain Injury
Interventions: Other: Non-pharmacological Individualized rehabilitative therapy; Other: Non-pharmacological Usual care therapy
Sponsors: University Health Network, Toronto; NeuroCatch Inc.
Recruiting
Randomized Trial of Radiosurgery vs Sham for Spasticity Associated With Stroke, SCI and Cerebral Palsy

Posted: October 6th, 2023, 2:00am GMT

Conditions: Spasticity as Sequela of Stroke; Spastic Cerebral Palsy; Spasticity, Muscle
Interventions: Radiation: stereotactic radiosurgery (SRS) dorsal root rhizotomy radiomodulation; Other: Sham
Sponsors: Ohio State University; Varian Medical Systems; Centro Diagnostico Milano, Co-PI: Pantaleo Romanelli, MD
Recruiting
Don't be Late! Postponing Cognitive Decline and Preventing Early Unemployment in People With Multiple Sclerosis

Posted: October 5th, 2023, 2:00am GMT

Conditions: Multiple Sclerosis
Interventions: Behavioral: Strenghtening the brain; Behavioral: Strengthening the mind
Sponsors: Amsterdam UMC, location VUmc; Universiteit Leiden; Personal Fitness Nederland; MS Vereniging Nederland; Merck BV; Genzyme, a Sanofi Company; MS Sherpa
Recruiting
National Registry of Rare Kidney Diseases

Posted: October 4th, 2023, 2:00am GMT

Conditions: Adenine Phosphoribosyltransferase Deficiency; AH Amyloidosis; AHL Amyloidosis; AL Amyloidosis; Alport Syndrome; Atypical Hemolytic Uremic Syndrome; Autoimmune Distal Renal Tubular Acidosis; Autosomal Recessive Proximal Renal Tubular Acidosis; Autosomal Recessive Distal Renal Tubular Acidosis; Autosomal Dominant Polycystic Kidney Disease; Autosomal Recessive Polycystic Kidney Disease; Bartter Syndrome; BK Nephropathy; C3 Glomerulopathy With Monoclonal Gammopathy; C3 Glomerulopathy; Calciphylaxis; Crystalglobulinaemia; Crystal-storing Histiocytosis; Cystinosis; Cystinuria; Dense Deposit Disease; Dent Disease; Denys-Drash Syndrome; Dominant Hypophosphataemia With Nephrolithiasis and/or Osteoporosis; Drug Induced Fanconi Syndrome; Drug-Induced Hypomagnesemia; Drug-Induced Nephrogenic Diabetes Insipidus; Epilepsy, Ataxia, Sensorineural Deafness and Tubulopathy; Fabry Disease; Familial Hypomagnesemia With Hypercalciuria and Nephrocalcinosis; Familial Primary Hypomagnesemia With Hypocalcuria; Familial Primary Hypomagnesaemia With Normocalciuria; Familial Renal Glucosuria; Fanconi Renotubular Syndrome 1; Fanconi Renotubular Syndrome 2; Fanconi Renotubular Syndrome 3; Fibrillary Glomerulonephritis; Fibromuscular Dysplasia; Focal Segmental Glomerulosclerosis; Generalised Pseudohypoaldosteronism Type 1; Gitelman Syndrome; Heavy-Metal-Induced Fanconi Syndrome; Hepatocyte Nuclear Factor 1-Beta-Associated Monogenic Diabetes; Hereditary Renal Hypouricemia; Hereditary Hypophosphatemic Rickets With Hypercalciuria; Hyperuricaemic Nephropathy; IgA Nephropathy; Immunotactoid Glomerulonephritis With Organised Microtubular Mononoclonal Immunoglobulin Deposits; Inherited Renal Cancer Syndromes; Intracapillary Monoclonal IgM Without Cryoglobulin; Intraglomerular/Capillary Lymphoma/Leukaemia; Isolated Autosomal Dominant Hypomagnesaemia Glaudemans Type; Liddle Syndrome; Light Chain Cast Nephropathy; Light Chain Proximal Tubulopathy Without Crystals; Light Chain Proximal Tubulopathy With Crystals; Lowe Syndrome; Membranous Nephropathy; Membranoproliferative Glomerulonephritis; Medullary Cystic Kidney Disease; Minimal Change Nephropathy; Mitochondrial Disease Of The Kidney; Monoclonal Immunoglobulin Deposition Disease; Nail Patella Syndrome; Nephrogenic Diabetes Insipidus; Nephrogenic Syndrome of Inappropriate Antidiuresis; Nephronophthisis; Primary Hypomagnesemia With Secondary Hypocalcemia; Primary Hyperoxaluria; Proliferative Glomerulonephritis With Monoclonal IgG Deposits; Proximal Tubulopathy Without Crystals; Pseudohypoaldosteronism Type 1, 2A-2E; Pure Red Cell Aplasia; Retroperitoneal Fibrosis; Sickle Cell Nephropathy; Shiga Toxin Associated Haemolytic Uraemic Syndrome; Steroid Resistant Nephrotic Syndrome; Steroid-Sensitive Nephrotic Syndrome; Thin Basement Membrane Nephropathy; Thrombotic Microangiopathy With Monoclonal Gammopathy; Type 1 Cryoglobulinaemic Glomerulonephritis; Tuberous Sclerosis; Unclassified Monoclonal Gammopathy Of Renal Significance; Vasculitis
Sponsors: UK Kidney Association
Recruiting
Effect of Intravenous Lignocaine Infusion on Intraoperative End Tidal Desflurane Concentration Requirements

Posted: October 3rd, 2023, 2:00am GMT

Conditions: Cholelithiases; Appendicitis; Ovarian Cysts
Interventions: Drug: Lignocaine; Drug: Placebo
Sponsors: Universiti Kebangsaan Malaysia Medical Centre
Completed
LAmbre Versus AMPLATZER Amulet Left AtrIal Appendage Occluder for StRoke ProphylaxIs

Posted: September 29th, 2023, 2:00am GMT

Conditions: Left Atrial Appendage Occlusion
Interventions: Device: Left Atrial Appendage Occlusion
Sponsors: Deutsches Herzzentrum Muenchen; Lifetech Scientific (Shenzhen) Co., Ltd.
Not yet recruiting
Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer

Posted: September 28th, 2023, 2:00am GMT

Conditions: Brain Cancer; Glioblastoma; Metastatic Cancer; Leptomeningeal Metastasis; Recurrent Glioblastoma
Interventions: Drug: Trastuzumab deruxtecan
Sponsors: Memorial Sloan Kettering Cancer Center; AstraZeneca
Recruiting
Rectal Cancer Survivorship: Impact of Low Anterior Resection Syndrome (LARS) on the Quality of Life

Posted: September 28th, 2023, 2:00am GMT

Conditions: Rectal Cancer; Low Anterior Resection Syndrome
Interventions: Behavioral: LARS score/ EORTC QLQ C30
Sponsors: University Hospital, Ghent
Completed
Tranexamic Acid in Nasal Mohs Reconstruction

Posted: September 27th, 2023, 2:00am GMT

Conditions: Postoperative Bleeding; Skin Cancer Face
Interventions: Drug: Treatment (tranexamic acid and 1% lidocaine with 1:100,000 epinephrine); Drug: Control (1% lidocaine with 1:100,000 epinephrine)
Sponsors: Vanderbilt University Medical Center
Not yet recruiting
Performance of Elucirem® in DSC-MRI Perfusion of Brain Gliomas

Posted: September 27th, 2023, 2:00am GMT

Conditions: Brain Tumor, Primary; Brain Tumor, Recurrent
Interventions: Drug: Elucirem; Drug: Dotarem
Sponsors: Guerbet
Recruiting
A Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid Tumors

Posted: September 27th, 2023, 2:00am GMT

Conditions: Malignant Solid Tumor
Interventions: Biological: GEN1042; Drug: Pembrolizumab; Drug: Cisplatin; Drug: Carboplatin; Drug: 5-Fluorouracil
Sponsors: Genmab; BioNTech SE
Recruiting
Feasibility of 18F-Fluciclovine PET/CT to Identify Brain Metastasis

Posted: September 27th, 2023, 2:00am GMT

Conditions: Brain Metastases
Interventions: Diagnostic Test: 18F-Fluciclovine (Axumin) PET/CT
Sponsors: University of Arizona; Blue Earth Diagnostics
Not yet recruiting
Frequency ,Etiology and Prognostic Factors of Acute Transverse Myelitis

Posted: September 27th, 2023, 2:00am GMT

Conditions: Transverse Myelitis
Interventions: Device: MRI
Sponsors: Assiut University
Not yet recruiting
Somatic Mosaicism in Twins Discordant for Childhood Cancer

Posted: September 26th, 2023, 2:00pm GMT

Conditions: Pediatric Central Nervous System Tumor; Central Nervous System Tumor; Discordant Twin; Somatic Mutation
Interventions: Other: Biospecimen collection; Other: Questionnaire Administration
Sponsors: Children's Oncology Group; National Cancer Institute (NCI)
Recruiting
Prognostic Indicators in Pituitary Adenoma Surgery: a Comprehensive Analysis of Surgical Outcomes and Complications.

Posted: September 25th, 2023, 2:00am GMT

Conditions: Pituitary Adenoma; Surgery-Complications
Sponsors: Central Hospital, Nancy, France
Completed

1 2 3 ... 12

← Trial - Brain Tumor Trial - Ganglioglioma →

Rare Cancer News & Clinical Trials » Trial - CNS Tumor

Feeds

Trial - CNS Tumor (100 unread)

Posted: December 1st, 2023, 3:00am GMT

Posted: November 30th, 2023, 3:00am GMT

Posted: November 30th, 2023, 3:00am GMT

Posted: November 29th, 2023, 3:00am GMT

Posted: November 29th, 2023, 3:00am GMT

Posted: November 29th, 2023, 3:00am GMT

Posted: November 27th, 2023, 3:00am GMT

Posted: November 27th, 2023, 3:00am GMT

Posted: November 24th, 2023, 3:00am GMT

Posted: November 24th, 2023, 3:00am GMT

Posted: November 22nd, 2023, 3:00am GMT

Posted: November 21st, 2023, 3:00am GMT

Posted: November 20th, 2023, 3:00am GMT

Posted: November 20th, 2023, 3:00am GMT

Posted: November 20th, 2023, 3:00am GMT

Posted: November 20th, 2023, 3:00am GMT

Posted: November 20th, 2023, 3:00am GMT

Posted: November 17th, 2023, 3:00am GMT

Posted: November 17th, 2023, 3:00am GMT

Posted: November 17th, 2023, 3:00am GMT

Posted: November 16th, 2023, 3:00am GMT

Posted: November 16th, 2023, 3:00am GMT

Posted: November 16th, 2023, 3:00am GMT

Posted: November 15th, 2023, 3:00am GMT

Posted: November 15th, 2023, 3:00am GMT

Posted: November 15th, 2023, 3:00am GMT

Posted: November 15th, 2023, 3:00am GMT

Posted: November 15th, 2023, 3:00am GMT

Posted: November 15th, 2023, 3:00am GMT

Posted: November 14th, 2023, 3:00am GMT

Posted: November 13th, 2023, 3:00am GMT

Posted: November 13th, 2023, 3:00am GMT

Posted: November 10th, 2023, 3:00am GMT

Posted: November 10th, 2023, 3:00am GMT

Posted: November 10th, 2023, 3:00am GMT

Posted: November 9th, 2023, 3:00am GMT

Posted: November 9th, 2023, 3:00am GMT

Posted: November 8th, 2023, 3:00am GMT

Fetched: November 7th, 2023, 5:01am GMT

Posted: November 7th, 2023, 3:00am GMT

Posted: November 7th, 2023, 3:00am GMT

Posted: November 6th, 2023, 3:00am GMT

Posted: November 6th, 2023, 3:00am GMT

Posted: November 6th, 2023, 3:00am GMT

Posted: November 3rd, 2023, 2:00am GMT

Posted: November 3rd, 2023, 2:00am GMT

Posted: November 3rd, 2023, 2:00am GMT

Posted: November 2nd, 2023, 2:00am GMT

Posted: November 2nd, 2023, 2:00am GMT

Posted: November 1st, 2023, 2:00am GMT

Posted: November 1st, 2023, 2:00am GMT

Posted: November 1st, 2023, 2:00am GMT

Posted: October 30th, 2023, 2:00am GMT

Posted: October 27th, 2023, 2:00am GMT

Posted: October 27th, 2023, 2:00am GMT

Posted: October 25th, 2023, 2:00am GMT

Posted: October 25th, 2023, 2:00am GMT

Posted: October 25th, 2023, 2:00am GMT

Posted: October 25th, 2023, 2:00am GMT

Posted: October 24th, 2023, 2:00am GMT

Posted: October 23rd, 2023, 2:00am GMT

Posted: October 23rd, 2023, 2:00am GMT

Posted: October 20th, 2023, 2:00am GMT

Posted: October 20th, 2023, 2:00am GMT

Posted: October 20th, 2023, 2:00am GMT

Posted: October 20th, 2023, 2:00am GMT

Posted: October 19th, 2023, 2:00am GMT

Posted: October 19th, 2023, 2:00am GMT

Posted: October 18th, 2023, 2:00am GMT

Posted: October 18th, 2023, 2:00am GMT

Posted: October 18th, 2023, 2:00am GMT

Posted: October 17th, 2023, 2:00am GMT

Posted: October 17th, 2023, 2:00am GMT